| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2140805 | Lung Cancer | 2013 | 7 Pages |
Abstract
Tumor-associated macrophages (TAMs) can be abundantly present in numerous cancer types. Under influence of various stimuli in the tumor microenvironment TAMs develop into a tumor-inhibitory (M1) or tumor-promoting (M2) phenotype. Recently, the role of TAMs in tumor biology and their prognostic value in cancer has become a major topic of interest. In this review we will discuss the importance of TAMs in the pathogenesis and clinical outcome of lung cancer and mesothelioma patients. In addition, the potential of TAMs as therapeutic targets will be discussed.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
L.A. Lievense, K. Bezemer, J.G.J.V. Aerts, J.P.J.J. Hegmans,